Skip to content

Drug interactions

Buprenorphine transdermal + Thioridazine

Severity: Major

Buprenorphine transdermal and Thioridazine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Transdermal buprenorphine can prolong the QT interval, and thioridazine does so strongly. The combination raises the risk of ventricular arrhythmias and also adds sedation.

What this interaction means in plain words

Buprenorphine transdermal and Thioridazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Additive QT prolongation and additive CNS depression.

What to do

Avoid if possible, and consider an alternative to thioridazine. If used together, monitor the ECG and sedation, and keep the buprenorphine dose as low as possible.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine transdermal and Thioridazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine transdermal with Thioridazine?

MediHelp rates the interaction as major. Buprenorphine transdermal and Thioridazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Transdermal buprenorphine can prolong the QT interval, and thioridazine does so strongly. The combination raises the risk of ventricular arrhythmias and also adds sedation.

How serious is the interaction between Buprenorphine transdermal and Thioridazine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible, and consider an alternative to thioridazine. If used together, monitor the ECG and sedation, and keep the buprenorphine dose as low as possible.

What other medicines interact with Thioridazine?

MediHelp also lists interactions of Thioridazine with, for example, Abiraterone, Adagrasib, Amiodarone. The full list is on the Thioridazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in